Quantcast

Latest Nitriles Stories

2011-11-04 21:01:30

In what is believed to be the first study of its kind to demonstrate an association between the antidepressant escitalopram and improved general pain, researchers from Boston University School of Medicine (BUSM), have found that opioid-dependent patients treated with escitalopram experienced meaningful reductions in pain severity and pain interference during the first three months of therapy. These findings appear in the journal Pain. Pain is common in opioid-dependent patients yet...

2011-07-12 00:00:56

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the antidepressant Zoloft, has launched a new Web site designed specifically to inform the public about links between the medication and various serious birth defects. New York, NY (PRWEB) July 11, 2011 According to a July 4, 2011, piece in the New York Times, an article published in the Archives of General Psychiatry reported "an elevated risk of autism in children whose mothers took a...

2011-01-19 08:04:20

(Ivanhoe Newswire) -- A new study shows antidepressants can help reduce hot flashes in menopausal women. In the study, Ellen Freeman, Ph.D., of the University of Pennsylvania School of Medicine, and her colleagues found that women who were either transitioning to menopause or were postmenopausal had less menopausal hot flashes when they used escitalopram (an antidepressant medication) compared to women who received placebo (a dummy medication or treatment). The researchers not only tested to...

2011-01-18 23:09:56

Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA. "Hormonal agents have been the predominant therapy for menopausal hot flashes, but their use decreased substantially following the shifts in risk-benefit ratios that were identified in the...

2010-11-03 04:22:00

NEW YORK, Nov. 3, 2010 /PRNewswire/ -- See video from Lundbeck at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=0c5e745c-050d-4fe3-8da5-8edbb8bc6db1&bhcp=1&alertid=d0b158ec-152f-49a0-a5a9-4a7a40807750# Danish-based H. Lundbeck A/S, a pharmaceutical company specialized in central nervous system (CNS) disorders, reports third quarter revenue of DKK 3,619 million, an increase of 7% compared to the third quarter results of 2009. Profit from operations (EBIT) was DKK...

2010-10-29 05:45:00

PHILADELPHIA, October 29, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in patients who have had residual symptoms of depression following treatment with LEXAPRO(R) (escitlopram) for Major Depressive Disorder (MDD). Based on these findings, Shire intends to advance discussions with regulators to explore...

2010-07-01 06:00:00

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300. (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) When using the...

2010-05-05 07:00:00

CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Sermo (http://www.sermo.com/client), the world's largest online community for physicians, today announced a Sermo Category Report titled Antidepressant Treatment Behaviors. The report surveyed more than 200 primary care physicians and covers a variety of topics including product choice drivers, treatment paths, referring habits, and overall issues in depression management. According to physician respondents, about 30% of their patients suffer from...

a92125d1c35152bd2317fa45d21de032
2010-04-02 11:15:00

The Federal Aviation Administration (FAA) is reversing its longstanding policy prohibiting antidepressant use among pilots, and will allow use of the medication in certain circumstances beginning Monday. According to an April 2 article by Mike Ahlers of CNN, the FAA believes that "pilots with mild to moderate depression will be allowed to fly while taking antidepressants if they can demonstrate they have been satisfactorily treated for at least 12 months." "The new policy will improve safety...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related